FDA Warning Letter to Neil R. Feins, M.D. 2009 05 20 Circare Is BPC 157 Legal? Understanding Its Status and Implications FDA considers adding a dozen peptides to its bulk drug compounding list RAPS The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA's Overreach on Compounded Peptides FDA Peptide Update: Category 2 Removals Explained